A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Objective Stem cell-based therapy can preserve cardiac function but is limited by the low cell retention within ischemic tissues. Injectable tissue engineering materials are well known for maintain cell survival and enhance cell-based therapies' effi cacy. We aimed to studying the usefulness of the combination of Injectable temperature-responsive chitosan hydrogel (as scaffold) and adipose-derived stem cells (ADSCs) to treat myocardial infarction. Methods Rat ADSCs were isolated fromdoi:10.1136/heartjnl-2011-300867.35 fatcat:yumvfpxuirh3nohe7j3vjgwmqi